Contact Us  
Site Map  
 


Legal Notification

PLEASE READ THESE TERMS AND CONDITIONS OF USE CAREFULLY BEFORE USING THIS WEBSITE.

These terms of use describe the terms and conditions that apply to your use of Sequenom Inc.'s ("Sequenom") Website. By using this Website, you provide your acceptance of these Terms and Conditions. If you do not agree to all of these Terms and Conditions, please exit this Website.

Sequenom may modify this Website and the rules and regulations governing its use, at any time. Modifications may be posted on the Website. By continuing use of the Website after such changes are made you will be accepting such changes.

This content of the website is intended to be a general information resource in regard to the subject matter covered, but is provided solely on an "AS IS" and "AS AVAILABLE" basis as noted on this page. Sequenom is not engaged in rendering medical or other professional services or advice via this Website, and the information provided is not intended to replace medical advice offered by a physician. If you desire or need such services or advice, you should consult a professional healthcare provider. You should not construe Sequenom's publication of this content as an endorsement by Sequenom of the views expressed herein, or any warranty or guarantee of any strategy, recommendation, treatment, action, or application of medication or preparation made by the author of the content.

  1. Scope of Use
  2. No Warranties
  3. Limitation of Liability
  4. A. Patents
    B. Trademarks
  5. Copyright
  6. Links
  7. User Submissions
  8. Security
  9. Location and Governing Law
  10. Violations and Additional Policies
  11. Safe Harbor

1. Scope of Use: Sequenom will allow you to view, use and download a single copy of this Website for your informational, non-commercial use. Except as otherwise provided herein, no part of any content or software on this Website may be copied, downloaded or stored in a retrieval system for any other purpose, nor may it be redistributed for any purpose, without the express written permission of Sequenom. You understand that Sequenom may discontinue, change, or restrict your use of this Website for any reason without notice.

2. No Warranties: ALL CONTENT ON THIS WEBSITE IS PROVIDED TO YOU ON AN "AS IS" "AS AVAILABLE" BASIS WITHOUT WARRANTY OF ANY KIND EITHER EXPRESS OR IMPLIED, INCLUDING BUT NOT LIMITED TO ANY IMPLIED WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, ACCURACY, AND NON-INFRINGEMENT. SEQUENOM MAKES NO WARRANTY AS TO THE ACCURACY, COMPLETENESS, CURRENCY, OR RELIABILITY OF ANY CONTENT AVAILABLE THROUGH THIS WEBSITE. YOU ARE RESPONSIBLE FOR VERIFYING ANY INFORMATION BEFORE RELYING ON IT. USE OF THE WEBSITE AND THE CONTENT AVAILABLE ON THE WEBSITE IS AT YOUR SOLE RISK. SEQUENOM MAKES NO REPRESENTATIONS OR WARRANTIES THAT USE OF THE WEBSITE WILL BE UNINTERRUPTED OR ERROR-FREE. YOU ARE RESPONSIBLE FOR TAKING ALL NECESSARY PRECAUTIONS TO ENSURE THAT ANY CONTENT YOU MAY OBTAIN FROM THE WEBSITE IS FREE OF VIRUSES.

THE ABOVE EXCLUSIONS MAY NOT APPLY IN JURISDICTIONS THAT DO NOT ALLOW THE EXCLUSION OF CERTAIN IMPLIED WARRANTIES.

3. Limitation of Liability: YOUR USE OF THE WEBSITE OR ANY CONTENT ON THE WEBSITE IS AT YOUR OWN RISK. SEQUENOM SPECIFICALLY DISCLAIMS ANY LIABILITY, WHETHER BASED IN CONTRACT, TORT, STRICT LIABILITY OR OTHERWISE, FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, OR SPECIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH ACCESS TO OR USE OF THE WEBSITE, EVEN IF SEQUENOM HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES, INCLUDING BUT NOT LIMITED TO RELIANCE BY ANY PARTY ON ANY CONTENT OBTAINED THROUGH THE USE OF THE WEBSITE, OR THAT ARISES IN CONNECTION WITH MISTAKES OR OMISSIONS IN, OR DELAYS IN TRANSMISSION OF, INFORMATION TO OR FROM THE USER, INTERRUPTIONS IN TELECOMMUNICATIONS CONNECTIONS TO THE WEBSITE OR VIRUSES, WHETHER CAUSED IN WHOLE OR IN PART BY NEGLIGENCE, ACTS OF GOD, TELECOMMUNICATIONS FAILURE, THEFT OR DESTRUCTION OF, OR UNAUTHORIZED ACCESS TO THE WEBSITE, OR RELATED INFORMATION OR PROGRAMS.

4A. Patents: The following United States patents are owned by or exclusively licensed to Sequenom:

US 4,920,264

Method for Preparing Samples for Mass Analysis by Desorption from a Frozen Solution

US 5,118,937

Process and Device for the Laser Desorption of Analyte Molecular Ions, Especially of Biomolecules

US 5,202,561

Device and Method for Analysing Ions of High Mass

US 5,464,985

Non-Linear Field Reflectron

US 5,503,980

Positional Sequencing by Hybridization

US 5,547,835

DNA Sequencing by Mass Spectrometry

US 5,605,798

DNA Diagnostic Based on Mass Spectrometry

US 5,622,824

DNA Sequencing by Mass Spectrometry via Exonuclease Degradation

US 5,631,134

Methods of Preparing Probe Array by Hybridization

US 5,691,141

DNA Sequencing by Mass Spectrometry

US 5,700,642

Oligonucleotide Sizing Using Immobilized Cleavable Primers

US 5,777,324

Method and Apparatus for MALDI Analysis

US 5,795,714

Method for Replicating an Array of Nucleic Acid Probes

US 5,804,436

Apparatus and Method for Real-Time Measurement of Cellular Response

US 5,830,655

Oligonucleotide Sizing Using Cleavable Primers

US 5,851,765

DNA Sequencing by Mass Spectrometry via Exonuclease Degradation

US 5,864,137

Mass Spectrometer

US 5,869,242

Mass Spectrometry to Assess DNA Sequence Polymorphisms

US 5,872,003

DNA Sequencing by Mass Spectrometry via Exonuclease Degradation

US 5,900,481

Bead Linkers for Immobilizing Nucleic Acids to Solid Supports

US 5,919,646

Apparatus and Method for Real-Time Measurement of Cellular Response

US 5,922,542

Diagnosis of Predisposition to Osteoporosis

US 5,928,906

Process for Direct Sequencing During Template Amplification

US 5,939,260

Methods of Diagnosing a Predisposition to Osteoarthritis via Detection of Vitamin D Receptor Gene Polymorphisms

US 5,965,363

Methods of Preparing Nucleic Acids for Mass Spectrometric Analysis

US 5,998,137

Methods of Diagnosis by Detecting Polymorphisms in the TGF-β1 Promoter

US 6,007,987

Positional Sequencing by Hybridization

US 6,022,688

Method for Dissociating Biotin Complexes

US 6,024,925

Systems and Methods for Preparing Low Volume Analyte Array Elements

US 6,043,031

DNA Diagnostics Based on Mass Spectrometry

US 6,051,378

Methods of Screening Nucleic Acids Using Mass Spectrometry

US 6,066,450

Diagnostic and Therapeutic Methods and Apparatus Based on Interleukin-6 Gene Polymorphisms

US 6,074,823

DNA Sequencing by Mass Spectrometry via Exonuclease Degradation

US 6,090,558

DNA Typing by Mass Spectrometry with Polymorphic DNA Repeat Markers

US 6,096,509

Apparatus and Method for Compound Profiling of Living Cells

US 6,104,028

Volatile Matrices for Matrix-Assisted Laser Desorption Ionization Mass Spectrometry

US 6,111,251

Method and Apparatus for MALDI Analysis

US 6,133,436

Beads Bound to a Solid Support and to Nucleic Acids

US 6,140,053

DNA Sequencing by Mass Spectrometry via Exonuclease Degradation

US 6,146,854

Filtration Processes, Kits and Devices for Isolating Plasmids

US 6,156,510

Polymorphisms in a Microsatellite Region of a Glucocorticoid Receptor Gene

US 6,194,144

DNA Sequencing by Mass Spectrometry

US 6,197,498

DNA Diagnostics Based on Mass Spectrometry

US 6,207,370

Diagnostics Based on Mass Spectrometric Detection of Translated Target Polypeptides

US 6,218,524

Genetic Polymorphisms in the Microsomal Triglyceride Transfer Protein Promoter and Uses Thereof

US 6,221,601

DNA Diagnostics Based on Mass Spectrometry

US 6,221,605

DNA Diagnostics Based on Mass Spectrometry

US 6,225,061

Systems and Methods for Performing Reactions in an Unsealed Environment

US 6,225,450

DNA Sequencing by Mass Spectrometry

US 6,235,478

DNA Diagnostics Based on Mass Spectrometry

US 6,238,871

DNA Sequencing by Mass Spectrometry

US 6,242,209

Cell Flow Apparatus and Method for Real-Time Measurements of Cellular Responses

US 6,258,538

DNA Diagnostics Based on Mass Spectrometry

US 6,265,716

Volatile Matrices for Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry

US 6,268,131

Mass Spectrometric Methods for Sequencing Nucleic Acids

US 6,268,144

DNA Diagnostics Based on Mass Spectrometry

US 6,277,573

DNA Diagnostics Based on Mass Spectrometry

US 6,280,967

Cell Flow Apparatus and Method for Real-Time Measurement of Cellular Responses

US 6,300,076

DNA Diagnostics Based on Mass Spectrometry

US 6,303,309

Method for Dissociating Biotin Complexes

US 6,312,897

Template-Directed Interference Footprinting of Protein-Adenine Contacts

US 6,322,970

Mass Spectrometric Detection of Polypeptides

US 6,379,917

Apparatus and Method for Real-Time Measurement of Cellular Response

US 6,387,628

Mass Spectrometric Detection of Polypeptides

US 6,423,966

Method and Apparatus for MALDI Analysis

US 6,428,955

DNA Diagnostics Based on Mass Spectrometry

US 6,436,635

Solid Phase Sequencing of Double-Stranded Nucleic Acids

US 6,440,705

Method for Analyzing Polynucleotides

US 6,458,945

Method for Analyzing Polynucleotides

US 6,468,748

Methods of Screening Nucleic Acids Using Volatile Salts in Mass Spectrometry

US 6,475,736

Methods for Genetic Analysis of DNA Using Biased Amplification of Polymorphic Sites

US 6,485,913

Systems and Methods for Performing Reactions in an Unsealed Environment

US 6,500,621

DNA Diagnostics Based on Mass Spectrometry

US 6,500,650

Method for Identifying Polymorphisms

US 6,528,268

Reagents and Methods for Detection of Heart Failure

US 6,558,902

Infrared Matrix-Assisted Laser Desorption/Ionization Mass Spectrometric Analysis of Macromolecules

US 6,558,916

Cell Flow Apparatus and Method for Real-Time Measurements of Patient Cellular Responses

US 6,566,055

Methods of Preparing Nucleic Acids for Mass Spectrometric Analysis

US 6,566,059

Method for Analyzing Polynucleotides

US 6,569,385

Systems and Methods for Preparing and Analyzing Low Volume Analyte Array Elements

US 6,582,923

Method for Analyzing Polynucleotides

US 6,589,485

Solid Support for Mass Spectrometry

US 6,602,662

DNA Diagnostics Based on Mass Spectrometry

US 6,610,492

Base-Modified Nucleotides and Cleavage of Polynucleotides Incorporating Them

US 6,635,452

Releasable Nonvolatile Mass Label Molecules

US 6,660,229

Use of Nucleotide Analogs in the Analysis of Oligonucleotide Mixtures and in Highly Multiplexed Nucleic Acid Sequencing

US 6,706,530

IR-MALDI Spectrometry of Nucleic Acids Using Liquid Matrices

US 6,723,564

IR-MALDI Spectrometry of Nucleic Acids Using Liquid Matrices

Sequenom has additional patents granted in various foreign countries and other United States and foreign patent applications pending.

Updated 23 April 2004

4B. Trademarks: Unauthorized use of any SEQUENOM trademark, service mark or logo may be a violation of federal and state trademark laws. SEQUENOM and SpectroCHIP are registered trademarks of Sequenom, Inc. MassARRAY®, MassEXTEND®, RealSNP, RealSNP.com, SNPCREDITS and any other marks so indicated are trademarks of SEQUENOM, Inc. All other trademarks or service marks set forth herein are the property of their respective owners.

5. Copyright: This Website is protected by U.S. and foreign copyright laws. Except for your informational, personal, non-commercial use as authorized above, you may not modify, reproduce or distribute the design or layout of the Website, or individual sections of the design or layout of the Website or any of the content within the website without Sequenom’s written permission.

6. Links: This Sequenom Website may contain links to Websites operated by other parties. The linked sites are not under the control of Sequenom, and Sequenom is not responsible for the content available on any other Internet sites linked to the Website. Such links do not imply Sequenom's endorsement of material on any other site and Sequenom disclaims all liability with regard to your access to such linked Websites. Sequenom provides links to other Internet sites as a convenience to users, and access to any other Internet sites linked to this Website is at your own risk. Unless otherwise set forth in a written agreement between you and Sequenom, you must adhere to Sequenom's linking policy as follows: (i) any link to the Website must be a text only link clearly marked "Sequenom Website," (ii) the appearance, position and other aspects of the link may not be such as to damage or dilute the goodwill associated with Sequenom's names and trademarks, (iii) the link must "point" to www.Sequenom.com and not to other pages within the Website, (iv) the appearance, position and other attributes of the link may not create the false appearance that your organization or entity is sponsored by, affiliated with, or associated with Sequenom, (v) when selected by a user, the link must display the Website on full-screen and not within a "frame" on the linking Website, and (vi) Sequenom reserves the right to revoke its consent to the link at any time and in its sole discretion.

7. User Submissions: Certain areas of this Website enable you to access online forums and to submit e-mails, or otherwise provide feedback to Sequenom. Sequenom does not endorse, and specifically disclaims any responsibility or liability for any content in the forums. In addition, Sequenom reserves the right to delete, move or edit content, in whole or in part, submitted to the forums that it, in its sole discretion, deems abusive, defamatory, obscene, in violation of intellectual property, privacy, or other proprietary rights, in violation of these terms and conditions, or for any other reason.

You agree that by submitting content, you:

  • will only submit content related to the subject matter of the forum, if applicable, and that complies with applicable law, and will not submit content that is abusive, defamatory, obscene, infringing, threatening, repetitive, or otherwise inappropriate, or that contains any viruses or other software that may adversely affect the operation of another's computer;
  • understand and agree that such content that is submitted to a forum, or feedback page, will be deemed non-confidential; and
  • grant to Sequenom the irrevocable right to use, copy, modify, publish, perform, transmit and display such content via any media in accordance with Sequenom's Privacy Policy, and waive any moral rights you may have in such content. Subject to Sequenom's Privacy Policy, Sequenom shall be free to use such content, including any ideas, concepts, know-how, or techniques contained in such content, for any reason whatsoeve

8.Security: You are responsible for maintaining the confidentiality of your registration number and password, and you are responsible for all uses of your registration number or password, and any and all related charges, whether or not authorized by you.

9. Location & Governing Law: This Website is operated by Sequenom from its offices in California, USA. The law of the State of California shall govern these terms and conditions, without reference to its choice of law rules. Sequenom makes no representation that the information in the Website is appropriate or available for use in other locations, and access to the Sequenom Website from territories where the content of the Sequenom Website may be illegal is prohibited. Those who choose to access the Sequenom Website from other locations do so on their own initiative and are responsible for compliance with applicable local laws.

10. Violations and Additional Policies: Sequenom reserves the right to seek all remedies available at law and in equity for violations of the rules and regulations set forth in this Website, including the right to block access from a particular Internet address to the Website.

11. Safe Harbor: Except for the historical information set forth in this Website and within its content, matters set forth in this Website and within its content, including but not limited to statements relating to, forthcoming products and applications, the potential for the generation of certain volumes and types of results using various products and applications, future diagnostic and therapeutic product development, and any statements relating to the Company's goals, plans, missions, expectations, beliefs, and the like, are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially, including the risks and uncertainties inherent in introducing new products and new product applications, drug discovery, development and commercialization, the risks and uncertainties associated with SEQUENOM's technologies and those of its competitors, and other risks detailed from time to time in SEQUENOM's SEC reports, including SEQUENOM's most recently filed Annual Report on Form 10-K and its most recently filed quarterly report. These forward-looking statements speak only as of the date hereof. SEQUENOM disclaims any intent or obligation to update these forward-looking statements.